Radiofrequency ablation for metastatic spinal lesions

Rosian K, Piso B
Record ID 32017000338
English
Authors' objectives: Many tumour patients develop painful vertebral metastases in the course of their disease that destroy the vertebrae and often do not adequately respond to standard therapies. We reviewed current evidence on efficacy and safety of radiofrequency ablation (RFA), a minimally invasive procedure, in patients with painful vertebral metastases.
Authors' recommendations: Four prospective and five retrospective single-arm studies were evaluated. Overall, the level of evidence for efficacy is not estimable and "very low" for safety outcomes. The current evidence suggests that RFA leads to a significant pain reduction and an improvement in health-related quality of life. Furthermore, no major complications occurred for the use of RFA. However, the studies have several limitations. Therefore, we recommend the inclusion of RFA in the Austrian BMGF catalogue of procedures with restrictions and suggest a re-evaluation after 2021.
Details
Project Status: Completed
URL for project: http://hta.lbg.ac.at/page/bewertung-medizinischer-einzelleistungen-mel-2017/en
Year Published: 2017
URL for published report: http://eprints.hta.lbg.ac.at/1131/1/DSD_108.pdf
URL for additional information: http://eprints.hta.lbg.ac.at/1131/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Austria
MeSH Terms
  • Catheter Ablation
  • Humans
  • Spine
Contact
Organisation Name: Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address: Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name: tarquin.mittermayr@aihta.at
Contact Email: office@aihta.at
Copyright: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.